16th Mar 2022 16:00
JPMORGAN ELECT PLC (the 'Company') | |
Legal Entity Identifier: 549300FIUYKKL39ILD07 | |
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 28 February 2022 | |
Managed Growth portfolio | |
JPMorgan American Inv Trust | 13.8% |
JPM UK Equity Plus C | 9.2% |
JPMorgan Claverhouse Inv Trust | 8.0% |
JPMorgan UK Dynamic C | 6.4% |
JPMorgan US Equity All Capital C | 6.3% |
Finsbury Growth & Income | 5.1% |
Murray Income Trust | 3.7% |
The Mercantile Inv Trust | 3.5% |
Fidelity | 3.3% |
JPMorgan US Value Fund | 3.3% |
Total | 62.5% |
Managed Income portfolio | |
Shell | 7.8% |
AstraZeneca | 6.0% |
BP | 4.1% |
Rio Tinto | 3.7% |
GlaxoSmithKline | 3.6% |
Barclays | 3.4% |
British American Tobacco | 3.3% |
OSB | 3.3% |
Computacenter | 2.8% |
HSBC | 2.7% |
Total | 40.7% |
* Based on invested portfolio | |
Name of contact and telephone number for queries: | |
Paul Ainger 0044 207 742 6524 | |
Name of authorised company official responsible for making this notification: | |
Priyanka Vijay Anand 0044 203 493 1504 - Company Secretary | |
Date: 16 March 2022 | |
Related Shares:
JPE.LJPEC.LJPEI.L